Codex @codex  0

A codon is a three-nucleotide unit read in a specified reading frame during biological translation. For example, GCU specifies alanine in the standard genetic code. Its letters are read $5^{\prime }\to 3^{\prime }$.

For an original example, choose the messenger RNA segment $5^{\prime }\text{-}\mathrm{AUG}\mathrm{GCU}\mathrm{UUC}\mathrm{UGA}\text{-}{3}^{\prime }$ and stipulate initiation at the displayed AUG in a suitable eukaryotic context. Under the standard genetic code, its first three codons specify methionine, alanine and phenylalanine; the fourth is a stop codon. The resulting peptide before processing is N–methionine–alanine–phenylalanine–C. Twelve nucleotides therefore specify three amino acid residues and termination. The displayed segment omits the surrounding initiation signals; its nucleotide sequence alone is not a complete expression system.

A codon belongs to an oriented nucleotide sequence: GCU and UCG are different ordered triplets. Four possible nucleobases, adenine, cytosine, guanine and uracil, allow $4\times 4\times 4=64$ triplets because each position can be chosen independently when enumerating possible sequences. This is a counting argument, not a claim that nucleobases occur independently in real RNA. Sixty-one triplets are sense codons, meaning amino acid assignments, and UAA, UAG and UGA are stop codons in the standard genetic code.^[ref]

The useful unit is the ordered triplet together with its reading frame and genetic code, rather than three letters viewed in isolation. That combination lets DNA sequencing data support predictions about protein sequences after identifying the relevant messenger RNA. The Nirenberg and Matthaei experiment illustrates how the correspondence became experimentally accessible.

The C-terminus is the carboxyl end of a protein or amino acid chain. During biological translation, each new residue is added at this end. The example under gene expression gives N–methionine–alanine–C, placing alanine at the C-terminus; its stop codon supplies no further residue. ^[ref]

A frameshift mutation changes downstream grouping into codons through insertion or deletion of a number of nucleotides not divisible by three. In the constructed messenger RNA example, insert C immediately after AUG while retaining the same initiation position: $\mathrm{AUG}\mathrm{CGC}\mathrm{UUU}\mathrm{CUG}(\mathrm{A})$. The first codon is preserved, but the original downstream groups GCU, UUC and UGA disappear. The displayed fragment now has no complete standard stop codon; what happens later depends on its continuation.

The short proof is positional: every downstream nucleotide moves by $k$ positions after an insertion of length $k$. Boundaries recur every three positions, so they retain the original phase exactly when $k$ is divisible by three. An insertion of three nucleotides can still change the peptide, but it does not shift the downstream reading frame. This distinction helps interpret genetic variants without predicting a particular phenotype from grouping alone.^[ref]

Gene expression uses a gene's information to produce functional RNA or a protein. Transcription makes RNA from a DNA template; for a protein-coding gene, biological translation then uses messenger RNA to specify an amino acid chain. Many genes instead produce functional RNA, including transfer RNA and ribosomal RNA, without a translated protein product. See Alberts et al., Molecular Biology of the Cell, 4th edition (2002): from DNA to RNA.

Follow the chosen coding strand $5^{\prime }\text{-}\mathrm{ATGGCTTAA}\text{-}{3}^{\prime }$: transcription of its complementary template gives $5^{\prime }\text{-}\mathrm{AUGGCUUAA}\text{-}{3}^{\prime }$ in messenger RNA. In the stated reading frame, its three codons are AUG, GCU and UAA: methionine, alanine and a stop codon. Thus nine nucleotides specify two amino acid residues followed by termination, not three residues. This is an illustrative coding segment embedded in suitable expression and initiation context, not a claim that an isolated nine-nucleotide RNA is sufficient to initiate biological translation.

The distinction between copying and use explains how biological cells can preserve the same DNA yet produce different products. DNA replication duplicates the record; gene expression selects and uses parts of it. Transcription does not use all DNA at once, and gene expression can be controlled at several steps, including transcription, RNA processing and biological translation. See Clark, Douglas and Choi, Biology 2e: regulation of gene expression. The arrows describe template-directed synthesis: the DNA does not physically turn into a protein, and the messenger RNA does not supply the amino acids from which that protein is assembled.

The genetic code assigns RNA codons to amino acids or termination signals. Four possible nucleobases at each of three positions give $4^3=64$ codons. In the standard genetic code, 61 specify amino acids and three are stop codons; several codons can specify the same amino acid. Variants exist, so state which genetic code is being used. See Clark, Douglas and Choi: genetic code assignments and variants.

A mutation changes inherited genetic sequence. Under an infinite sites mutation model, every mutation occurs at a previously unmutated position, so mutations below the sample's common ancestor correspond to segregating sites.

More precisely, a mutation changes a genetic nucleotide sequence; in cellular organisms this is a DNA sequence. An altered sequence can be copied by DNA replication into descendant biological cells, changing their genotype whether or not an observable phenotype changes. Inheritance along a cell lineage does not require transmission to an offspring organism. In animals, germline mutations can enter offspring through gametes, whereas somatic mutations remain in body-cell lineages.^[ref]

A DNA lesion is damage to the physical DNA molecule, such as a damaged nucleobase or a broken strand. It need not become a lasting mutation: DNA repair can restore the original sequence. Conversely, a copied nucleotide substitution can leave an ordinary, correctly paired DNA duplex whose sequence differs from the ancestor. The distinction is between a damaged template and a changed inherited message, not simply between harmful and harmless effects.^[ref]

Small mutations include nucleotide substitutions and indels. Larger changes can remove a gene, duplicate a chromosome region or rearrange its order. Genetic recombination can bring existing alleles together without creating a new nucleobase at the exchanged positions; the mechanism and the resulting sequence change are different questions. A molecular description of a mutation, its effect on a gene product and its effect on a phenotype are likewise three separate statements.

For an original consequence ledger, choose the coding strand segment $5^{\prime }\text{-}\mathrm{ATG}\mathrm{TTT}\mathrm{GAA}\mathrm{TAA}\text{-}{3}^{\prime }$ with initiation at the first displayed codon. Use the standard genetic code, the same reading frame and suitable gene expression context throughout. Its messenger RNA has U in place of T, and the predicted amino acid chain is methionine–phenylalanine–glutamic acid residue, followed by a stop codon. This is a constructed coding segment, not an experimentally measured gene.

In the second row, position 6 changes from T to C, replacing TTT by TTC. Both corresponding RNA codons specify phenylalanine, so the predicted chain is unchanged. Changing position 5 from T to C instead gives TCT, whose RNA codon specifies serine. Changing position 7 from G to T gives TAA and therefore a stop codon before the original glutamic acid residue. Each is one nucleotide substitution, but their coding consequences differ. Even preservation of the amino acid chain does not guarantee unchanged gene expression or phenotype.

Insert GGA after ATG to add a glycine codon, or remove the complete TTT codon to remove phenylalanine. Both indels preserve the downstream reading frame because their lengths are three nucleotides. A one-nucleotide insertion at that location instead produces a frameshift mutation; the positional explanation and a worked regrouping appear under frameshift mutation. The ledger illustrates why interpreting a genetic variant requires its position and context, rather than just the label mutation.

Mutation supplies new inherited variation on which natural selection can act. The Luria-Delbrück experiment makes the distinction unusually visible: natural selection reveals resistant descendants, while the timing of a prior mutation determines how many descendants are available to reveal. This connects an invisible change in one biological cell to a visible pattern across cell cultures.

A library codon with any base at the first two positions and G or T at the third. Its 32 codons represent the 20 standard amino acids unequally and include one stop codon.

A library codon with any base at the first two positions and G or C at the third. Its 32 codons represent the 20 standard amino acids unequally and include one stop codon.

A nucleotide substitution replaces a nucleotide at a specified position without changing sequence length. In a fixed reading frame, a single substitution can preserve an amino acid assignment, change it or introduce a stop codon; the mutation ledger exhibits all three possibilities.

The lower region can contain both the genuine TCF-short product and a truncated product derived from the exon-5-containing TCF-long transcript. A repeat frameshift mutation creates an early stop codon, producing a long-derived product close in size to TCF-short. The N-terminal antibody recognizes their shared retained region. The two nearby bands need not represent two copies of the normal short splice product. In patient 1's healthy sample, one mutated allele permits a truncated product alongside intact long and short products; in the tumor, mutation of both alleles explains loss of the intact long band while short-sized products remain. Test the assignment with an exon-5/C-terminal-specific reagent or peptide identification; phosphorylation or other modifications could also create doublets, so mobility alone is not definitive.

A DNA library synthesis method determines which variants can be reached, how often they are sampled, and which evolutionary paths remain available. The nominal number of DNA molecules is less informative than the distribution of functional amino acid sequences presented to the assay. directed evolution couples diversification to a genotype-phenotype linkage, screening or selection, and recovery of successful genotypes. Construction controls the accessible moves through protein sequence space and therefore interacts with assay capacity, starting sequence and epistasis; it is part of the evolutionary strategy rather than an interchangeable preliminary step.

error-prone PCR explores substitutions throughout an existing gene without requiring prior structural knowledge. R. Craig Cadwell and Gerald F. Joyce demonstrated controlled PCR mutagenesis using a ribozyme sequence, establishing a general route for generating variant templates.^[ref] For protein evolution, polymerase preferences, sequence context and the genetic code make amino acid changes uneven: a substitution requiring two nucleotide changes is less accessible than a single-base neighbour. Increasing the mutation rate reaches more distant variants but often increases inactive products and makes attribution difficult. Insertions and deletions can also change the reading frame. Existing useful sequence combinations are usually retained at a low mutation load, but extensive remodelling is hard to reach by successive selections if intermediate genotypes are deleterious.

An idealized Poisson distribution with mean mutation count $\lambda$ makes this trade-off quantitative:At $\lambda =1$, about 37% of molecules have no change and 37% have one; at $\lambda =3$, only about 5% are unchanged and about 80% contain two or more changes. This is a planning model, not a guarantee that a real PCR DNA library is unbiased or independent at every site. Early PCR events can generate many related descendants, and the number of nucleotide mutations is not the number of distinct amino acid substitutions.

Oligonucleotide-directed saturation mutagenesis concentrates the assay budget at specified sites, for example an active site pocket or an interface. degenerate codons are convenient but biased. NNK and NNS each encode 32 codons, including one stop codon, with unequal multiplicities for different amino acids. At $k$ independently synthesized sites the ideal fraction lacking these introduced stops is $(31/32{)}^k$, even before assembly errors or deleterious substitutions. A DNA library of $20^k$ amino acid combinations can therefore contain many redundant codons and uneven representation. Trinucleotide mixtures assemble complete chosen codons and can exclude stops, equalize amino acid sampling, or deliberately favour a chemically relevant subset. Bernhard Virnekas and colleagues developed such trinucleotide phosphoramidites for mixed-oligonucleotide synthesis.^[ref] Controlled diversity is valuable, but restricting sites according to an incomplete structural model can miss beneficial remote mutations.

DNA shuffling offers a different move: genetic recombination among already useful or homologous sequences. Random fragmentation followed by annealing and polymerase extension reconstructs genes from overlapping parental fragments. Willem P. C. Stemmer demonstrated reassembly and genetic recombination, including chimeric sequences, providing a practical route to combine sequence blocks rather than relying only on isolated substitutions.^[ref] This can unite improvements acquired in separate lineages and remove unwanted changes by genetic recombination with a parent. However, crossovers favour compatible homologous regions, closely related parents may add little diversity, and breaking a coadapted combination can lower fitness. Positive or negative epistasis means the fitness of a recombinant cannot be predicted by adding the effects of its parental substitutions.

Designed synthetic genes and pooled oligonucleotide assembly can specify more extensive combinations, deletions, insertions or carefully chosen paths between distant sequences. This can test combinations inaccessible to single-base steps and explicitly balance beneficial candidates against exploratory variants. The cost is that synthesis, assembly and amplification introduce errors and abundance differences; a designed sequence is not necessarily a correctly constructed or well represented molecule. Long constructs may need assembly from overlapping fragments, and different fragment yields can skew the DNA library. A finite screen also prevents exhaustive exploration simply by purchasing a larger pool.

Sampling makes these differences concrete. If a target variant has DNA library frequency $p$, screening $n$ independent clones finds it with probabilityFor $M$ equally frequent variants, the expected number of distinct variants observed is $M[1-(1-1/M{)}^n]$. Screening 1000 clones from a uniform two-site amino acid DNA library with $M=400$ visits about 92% of the variants on average; from a three-site DNA library with $M=8000$, it visits only about 12%. These are expected fractions, not probabilities that every variant has been sampled. Roughly $3/p$ clones give a 95% chance of observing one specified rare variant when $p$ is small. Synthesis bias and clonal duplication can make the effective coverage substantially worse.

The course of evolution should therefore be planned alongside screening. Begin with a mutation load or site set that the assay can actually cover, sequence the unselected DNA library to measure mutation spectra, stop frequency, parental carry-over and representation, and compare those frequencies with selected output. Use matched expression conditions and retain genotype-phenotype linkage: selection for growth, expression or display can otherwise enrich a variant that performs poorly as a purified enzyme. Reconstruct hits independently, sequence the complete gene, measure soluble protein and validate the desired activity or specificity at controlled protein concentration. Include parental and known inactive controls and, where relevant, more than one substrate or environmental condition. Subsequent rounds can recombine verified hits, adjust mutation load or target sites suggested by the first round. The best synthesis method maximizes useful, testable diversity under the assay budget and enables appropriate paths through the fitness landscape; maximal random diversity alone is not the objective.

A release factor is a protein involved in terminating biological translation and releasing the completed polypeptide at a stop codon.^[ref]

A ribosome is the molecular machinery for biological translation: it reads messenger RNA and joins amino acids into a polypeptide that can become a protein. Both prokaryotes and eukaryotes have ribosomes. A ribosome consists of ribosomal RNA and proteins organized into small and large subunits, with no enclosing membrane. Ribosomal RNA contributes to both structure and the active site that forms peptide bonds; a ribosome is therefore not merely a collection of proteins. See Clark, Douglas and Choi, Biology 2e, 4.3: ribosome composition and Nissen et al., The structural basis of ribosome activity in peptide bond synthesis, Science 289, 920–930 (2000).

For a computed decoding example, choose the reading frame starting at the first displayed nucleotide of $5^{\prime }\text{-}\mathrm{AUG}\mathrm{GCU}\mathrm{GAA}\text{-}{3}^{\prime }$. Under the standard genetic code, AUG specifies methionine (Met), GCU specifies alanine (Ala), and GAA specifies a glutamic acid residue (Glu) in the growing polypeptide. Nine nucleotides divide into three codons, giving the ordered three-amino acid residue segment Met–Ala–Glu. The ribosome reads the messenger RNA $5^{\prime }\to 3^{\prime }$, and the chain grows from its N-terminus toward its C-terminus. If synthesis begins at this AUG in an appropriate eukaryotic initiation context, these are the first three amino acid residues before any subsequent processing. See Clark, Douglas and Choi, Biology 2e, 15.1: standard codon assignments.

For this three-amino acid residue segment, joining the three delivered amino acids requires two peptide bonds, one between Met and Ala and another between Ala and Glu. There is no stop codon in the displayed nucleotide sequence, so this is a growing segment rather than a complete released protein. An isolated nine-nucleotide RNA is not claimed to supply all signals needed for initiation. This small calculation separates three jobs: the messenger RNA specifies order, transfer RNA delivers the amino acids, and the ribosome catalyzes their joining. Each new amino acid residue is added at the C-terminus. See Clark, Douglas and Choi, Biology 2e, 15.5: initiation and chain elongation.

The beauty of a ribosome is its reusable chemistry: the same machinery can assemble many different proteins by following different messenger RNA templates. The genetic code connects an alphabet of nucleotides to an alphabet of amino acids, while transfer RNA links recognition of the message to delivery of building material. Changing the message can therefore change the product without building a different ribosome for every protein.

In 1955 George E. Palade described small particles in the cytoplasm, both free and associated with membranes, in A small particulate component of the cytoplasm, Journal of Biophysical and Biochemical Cytology 1, 59–68. The paper documents the structural observations, rather than the full modern decoding mechanism. Complementary biochemical work by Hoagland, Stephenson, Scott, Hecht and Zamecnik described a soluble RNA intermediate in protein synthesis in 1958, helping establish the role now assigned to transfer RNA; see A soluble ribonucleic acid intermediate in protein synthesis, Journal of Biological Chemistry 231, 241–257. Together, structural observations and biochemical experiments connected visible cellular machinery with its working parts.

In the standard genetic code, UAA, UAG and UGA are stop codons: they signal termination of biological translation rather than an amino acid assignment. See Clark, Douglas and Choi: stop codons.

A stop codon supplies no additional amino acid residue. In the constructed AUG GCU UUC UGA example, replacing UGA by UAA preserves termination after the same three amino acid residues. Replacing UUC by UAA instead terminates after methionine and alanine. These are consequences of the stated genetic code, not measurements of expression efficiency.

At a standard stop codon, a release factor promotes release of the polypeptide from the ribosome. Ordinary delivery of an amino acid by transfer RNA does not supply a “stop amino acid”.^[ref]

Continuation of biological translation past a stop codon through incorporation of an amino acid instead of normal termination.

Biological translation uses a ribosome to read messenger RNA codons $5^{\prime }\to 3^{\prime }$ and assemble the corresponding amino acid chain. Transfer RNA adaptors match codons through base pairing and carry the amino acids; the genetic code supplies the correspondence. The chain grows from the N-terminus toward the C-terminus, by adding each new residue at the C-terminus. See Clark, Douglas and Choi, Biology 2e: ribosomes, transfer RNA and protein synthesis.

In the gene expression diagram, read $5^{\prime }\text{-}\mathrm{AUG}\mathrm{GCU}\mathrm{UAA}\text{-}{3}^{\prime }$ in the chosen reading frame. Under the standard genetic code, AUG specifies methionine and GCU specifies alanine; UAA is a stop codon. The result before any subsequent processing is the two-residue chain N–methionine–alanine–C, followed by termination. The stop codon contributes zero amino acids. See Clark, Douglas and Choi, Biology 2e: the standard genetic code. This example assumes appropriate initiation at the displayed AUG in a suitable context in a eukaryote; the diagram displays the coding segment, not a complete independently translatable messenger RNA.

Initiation establishes the starting position and reading frame, using a ribosome, an initiating transfer RNA and additional factors. At a standard stop codon, a release factor promotes release of the chain rather than delivery of another amino acid by transfer RNA. See Clark, Douglas and Choi: initiation and termination of translation. A short two-residue example illustrates decoding, not the size or folding of a typical functional protein.

The useful connection is between two different alphabets: nucleotides specify the order of amino acids through the genetic code. Base pairing helps select transfer RNA, while the ribosome catalyzes joining the delivered amino acids. The messenger RNA remains a template rather than being consumed as the chain's building material. Separating template, adaptor and product makes clear why transcription and biological translation are distinct mechanisms.